Earnings History Data for Biote Corp. (BTMD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Biote Corp.
BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | BTMD | Biote Corp. | 301.45 | 0.33 | 0.09 | -0.11 | BIOTE GAAP EPS of $0.33 beats by $0.26, revenue of $51.4M in-line [11/12/2024 4:42 PM] |
6.71 | 1.20 (21.65%) |
5.60 | 0.08 (1.45%) |
3.65 - 8.44 | 611,742 | 100,000 | 1,154 | ||
| 08-08-2024 | PM | BTMD | Biote Corp. | 434.88 | 0.14 | 0.09 | 0.44 | BIOTE reports Q2 GAAP EPS of -$0.19 [8/9/2024 8:22 AM] |
5.41 | -1.36 (-20.16%) |
6.89 | 0.12 (1.77%) |
3.65 - 8.44 | 430,907 | 170,000 | 2,150 | ||
| 07-05-2024 | AH | BTMD | biote Corp. | 431.00 | 0.23 | 0.05 | 0.00 | 6.07 | 0.30 (5.20%) |
0.0 | 0.0 (0.00%) |
3.65 - 8.22 | 120,192 | 60,000 | 0 | |||
|
|
||||||||||||||||||
| 12-03-2024 | AH | BTMD | Biote Corp. | 410.36 | 0.14 | 0.08 | 0.18 | BIOTE GAAP EPS of $0.18 beats by $0.11, revenue of $45.7M in-line [3/12/2024 4:17 PM] |
6.08 | 0.78 (14.72%) |
0.0 | 0.0 (0.00%) |
3.65 - 8.22 | 271,979 | 110,000 | 0 | ||
| 07-11-2023 | AH | BTMD | Biote Corp. | 415.13 | -0.11 | 0.07 | -0.09 | BIOTE GAAP EPS of $0.24, revenue of $45.6M [11/7/2023 5:17 PM] |
4.42 | -1.39 (-23.92%) |
5.80 | -0.01 (-0.17%) |
2.75 - 8.22 | 327,087 | 50,000 | 1,231 | ||
| 10-08-2023 | AH | BTMD | Biote Corp. | 473.79 | 0.44 | 0.09 | 0.27 | BIOTE GAAP EPS of -$0.25 misses by $0.37, revenue of $49.26M misses by $0.76M [8/11/2023 1:27 PM] |
5.60 | -0.88 (-13.58%) |
5.36 | -1.12 (-17.28%) |
2.75 - 8.22 | 1,059,178 | 80,000 | 16,909 | ||
| 09-05-2023 | AH | After the close (May 9) |
BTMD | Biote Corp. | 54.58 | 0.94 | 0.09 | 0.00 | Biote reports Q1 results, maintains FY 2023 revenue guidance [5/9/2023 7:09 PM] |
5.69 | -0.71 (-11.16%) |
5.40 | -1.00 (-15.62%) |
2.00 - 10.52 | 491,857 | 30,000 | 17,133 | |
| 28-03-2023 | AH | After the close (Mar 28) |
BTMD | Biote Corp. | 51.59 | 0.18 | 0.14 | 0.00 | BIOTE GAAP EPS of $0.18 beats by $0.04, revenue of $44.5M beats by $0.67M [3/28/2023 4:22 PM] |
5.30 | 0.57 (12.05%) |
4.55 | -0.18 (-3.81%) |
2.00 - 10.52 | 65,094 | 80,000 | 3,147 | |
| 08-11-2022 | AH | 4:55 PM ET (Nov 8) |
BTMD | Biote Corp. | 32.57 | N/A | 0.14 | 0.00 | BIOTE EPS of -$1.74, revenue of $42M in-line [11/8/2022 11:37 PM] |
4.03 | 0.05 (1.13%) |
0.0 | 0.0 (0.00%) |
2.00 - 10.52 | 23,836 | 20,000 | 0 | |
| 09-08-2022 | AH | After the close (Aug 9) |
BTMD | biote Corp. | 166.00 | N/A | 0.14 | 0.00 | BIOTE reports Q2 results; maintains FY 2022 revenue guidance & raises adjusted EBITDA outlook [8/9/2022 5:21 PM] |
4.45 | 0.13 (3.01%) |
0.0 | 0.0 (0.00%) |
2.00 - 10.53 | 71,842 | 0 | 0 | |